Genome-Wide CRISPR Screen Identifies Multiple Synthetic Lethal Targets That Enhance KRAS (G12C) Inhibitor Efficacy [RNA-seq-human]
Transcriptomic analysis of NSCLC cells  either under MRTX849 treatment or Ctrl (DMSO) to identify key pathways causing resistance. Overall design: Comparative gene expression profiling analysis of RNA-seq data for MRTX-849 Treated NSCLC cells- H2030 and H2122